John Mei is an associate in Goodwin’s Business Law Department and a member of its nationally recognized Technology and Life Sciences group. Mr. Mei represents issuers and underwriters in capital markets transactions, primarily in the life sciences and biotechnology industry, including in initial public offerings, follow-on offerings, at-the-market offerings, and convertible and investment-grade debt offerings. Mr. Mei also represents public and private companies in securities law, corporate governance and general corporate matters, including SEC reporting, Nasdaq/NYSE compliance, and preparation of board and committee materials.

Mr. Mei also has experience representing buyers, sellers and financial advisors in public and private mergers, acquisitions, divestitures and joint ventures and representing borrowers and lenders in finance transactions, including secured and unsecured credit facilities and royalty monetizations.

Prior to joining Goodwin in 2019, Mr. Mei was an associate at Covington & Burling LLP in New York.

Mr. Mei is admitted to practice in New York only; his application to the Massachusetts bar is pending. He is working under the supervision of the partners at Goodwin.

Areas of Practice
TÄTIGKEITSFELDER
Domaines D’Expertise
业务范围

Experience

ERFAHRUNG

EXPÉRIENCE

工作经历

Mr. Mei’s recent representations include:

  • Repligen Corporation, a bioprocessing company focused on products used to manufacture and purify biologic drugs, in concurrent underwritten public offerings of common stock and convertible senior notes that, together, account for $425.6 million in gross proceeds.
  • Amarin Corporation plc, a pharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, in a $460 million underwritten public offering of American depositary shares.
  • Clinical-stage immuno-oncology company in SEC reporting, corporate governance matters and multiple public offerings totaling over $250 million.*
  • Fully integrated biopharmaceutical company focused on autoimmune, inflammatory and fibrotic diseases in SEC reporting, corporate governance matters and an at-the-market offering.*
  • Underwriters in the $67 million initial public offering, two follow-on offerings (totaling over $230 million) and an at-the-market offering by an Israeli clinical-stage urologic oncology company.*
  • Underwriters in three follow-on offerings (totaling over $90 million) and an at-the-market offering by a Dutch clinical-stage immuno-oncology company.*
  • Global animal health company in multiple investment-grade notes offerings totaling over $4.0 billion.*

* Denotes experience prior to joining Goodwin

In The News

MELDUNGEN

ACTUALITÉS

相关新闻

Credentials

WERDEGANG

RÉFÉRENCES

专业资格

Education

J.D., 2014
New York University Law School
B.A., 2011
Dartmouth College

Admissions

Bar

New York
Get In Touch
Kontakt
NOUS CONTACTER
联系我们
Our clients rely on us for world-class advisory services, counsel on complex transactional work and high-stakes litigation. Specializing in matters involving the financial, life sciences, private equity, real estate, and technology industries, we use a collaborative, cross-disciplinary approach to resolve our clients’ most challenging issues. To find out more, please contact us.

Unsere Kunden verlassen sich auf unsere erstklassige Beratung, vor allem im Hinblick auf komplexe Transaktionen und High-Stakes-Prozesse. Spezialisiert auf Angelegenheiten der Finanz-, Life-Sciences-, Private-Equity-, Immobilien-und Technologie-Branchen, verwenden wir einen kooperativen und interdisziplinären Ansatz, um Fragen unserer Kunden auch in extremen Spezialsituationen einer Lösung zuzuführen. Sie wollen mehr erfahren? Kontaktieren Sie uns gerne.

Nos équipes interviennent aux côtés de nos clients, industriels, fonds d’investissement, startups, institutions financières et dirigeants, dans le cadre de transactions et de contentieux complexes, et apportent des conseils de tout premier plan dans les secteurs financiers, des Sciences de la Vie, du Private Equity, de l’immobilier et des technologies. Nous traitons les dossiers juridiques de manière intègre, ingénieuse, souple et audacieuse pour répondre efficacement aux enjeux propres à chacun de nos clients, quels que soient la taille de l’opération et le secteur d’activité. Pour en savoir plus, contactez-nous.

客户信赖我们世界一流的咨询服务,希望获得针对复杂事务性工作与高风险诉讼的建议。我们通过协作式、跨领域的工作方法来解决客户最棘手的问题,涵盖金融、生命科学、私募股权、不动产和技术等多个行业。如需更多信息,请与我们联系。

Search Other Lawyers
ANWALTSSUCHE
Recherche par Pratique
搜寻其他律师